Cuellar Sandra
From UI Health, Chicago, Illinois.
J Adv Pract Oncol. 2024 Apr;15(3):182-185. doi: 10.6004/jadpro.2024.15.3.5. Epub 2024 Apr 1.
During JADPRO Live 2023, Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Cuellar highlighted new drug classes, novel mechanisms of action, and safety profiles that advanced practitioners should be aware of.
在2023年JADPRO直播活动中,药学博士、肿瘤药学委员会认证专家(BCOP)、肿瘤药学协会会员(FHOPA)、美国卫生系统药师协会会员(FASHP)桑德拉·奎拉尔讨论了处于药物研发阶段的研究性治疗药物。奎拉尔博士强调了高级从业者应了解的新药物类别、新作用机制和安全性概况。